Clinical Trial Update: Study of INCB086550 in Select Solid Tumors [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating INCB086550 across select solid tumors, including non-small cell lung cancer and urothelial carcinoma, was terminated with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Melanoma
• Non-small Cell Lung Cancer
• Renal Cell Carcinoma
• Urothelial Carcinoma

Drugs mentioned

• INCB086550 (INCB086550)

Snippet

Sponsor: Incyte Corporation | Conditions: Non Small Cell Lung Cancer, Urothelial Cancer | Phase 2 | Status: TERMINATED | Results posted: 2025-03-13